300
Participants
Start Date
November 18, 2019
Primary Completion Date
July 23, 2026
Study Completion Date
July 23, 2026
Olaparib
Oral tablet
Pembrolizumab
Intravenous infusion
Riga East Clinical University Hospital ( Site 2103), Riga
Vaal Triangle Oncology Centre ( Site 1905), Vereeniging
Blacktown Hospital ( Site 2202), Blacktown
Wits Clinical Research ( Site 1906), Parktown-Johannesburg
Monash Medical Centre ( Site 2205), Clayton
Liepaja Regional Hospital ( Site 2101), Liepāja
The Oncology Centre ( Site 1904), Durban
Tasman Oncology Research Pty Ltd ( Site 2203), Southport
Daugavpils Regional Hospital ( Site 2104), Daugavpils
Linear Clinical Research Ltd ( Site 2206), Nedlands
Cancercare Rondebosch Oncology ( Site 1901), Rondebosch
Universitas Annex National Hospital ( Site 1902), Bloemfontein
Zhytomyr Regional Oncology Center ( Site 1710), Zhytomyr
New York Cancer and Blood Specialists-Research Department ( Site 0080), Port Jefferson Station
Charite-Universitaetsmedizin Berlin-Campus Benjamin Franklin ( Site 0902), Berlin
Seoul National University Bundang Hospital ( Site 2403), Seongnam-si
Oncosalud ( Site 3200), Lima
Instituto Nacional de Enfermedades Neoplasicas ( Site 3201), Lima
Hospital Nacional Arzobispo Loayza ( Site 3208), Lima
Clinica San Gabriel ( Site 3202), Lima
Hospital Nacional Cayetano Heredia ( Site 3203), Lima
Cherkasy Regional Oncology Dispensary ( Site 1702), Cherkasy
ASST Grande Ospedale Metropolitano Niguarda ( Site 0700), Milan
Podillya Regional Center of Oncology ( Site 1708), Vinnytsia
Trakya University Medical Faculty Balkan Oncology Hospital ( Site 1500), Edirne
Inova Schar Cancer Institute ( Site 0008), Fairfax
Kirovograd Regional oncology Dispensary ( Site 1716), Kropyvnytsky
CHU Jean Minjoz ( Site 0606), Besançon
Hospital General Universitario Gregorio Maranon ( Site 1300), Madrid
Hospital Quiron de Madrid ( Site 1301), Pozuelo de Alarcón
Khmelnitskiy Regional Onkology Dispensary ( Site 1705), Khmelnitskiy
Northwest Georgia Oncology Centers PC ( Site 0047), Marietta
Winship Cancer Institute of Emory University ( Site 0057), Atlanta
Northeast Georgia Medical Center ( Site 0026), Gainesville
University of Florida ( Site 0078), Gainesville
Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 1504), Istanbul
Institut du Cancer de Montpellier ( Site 0610), Montpellier
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi ( Site 1505), Istanbul
Ege Universitesi Tip Fakultesi Tulay Aktas Onkoloji Hastanesi ( Site 1501), Izmir
The Kirklin Clinic ( Site 0086), Birmingham
Preparaciones Oncologicas ( Site 3102), León
Norton Cancer Institute - St. Matthews ( Site 0024), Louisville
Azienda Ospedaliero Universitaria di Modena Policlinico ( Site 0703), Modena
Necmettin Erbakan Universitesi Meram Tip Fakultesi ( Site 1510), Konya
University Hospitals Cleveland Medical Center ( Site 0016), Cleveland
Inonu Universitesi Medical Fakultesi ( Site 1506), Malatya
Municipal Non-Profit Enterprise City Clinical Hospital 4 of Dnipro City Council ( Site 1700), Dnipro
Universitaetsklinik Koeln ( Site 0903), Cologne
Azienda Ospedaliera Universitaria Senese ( Site 0704), Siena
Communal non profit enterprise Regional Clinical Oncology Center ( Site 1704), Kharkiv
Unidad Biomedica Avanzada Monterrey S. A. ( Site 3108), Monterrey
Centro Medico Zambrano Hellion ( Site 3105), San Pedro Garza García
Fundacion Cardiovascular de Colombia ( Site 2907), Piedecuesta
Medical center of the Limited Liability Company Yulis ( Site 1714), Zaporizhzhia
Clinica Integral Internacional de Oncologia S. de R.L. de C.V. ( Site 3107), Puebla City
The University of Oklahoma Health Sciences Center ( Site 0050), Oklahoma City
Parkland Health & Hospital System ( Site 0091), Dallas
University of Texas, Southwestern Medical Center ( Site 0004), Dallas
Hospital H+ Queretaro ( Site 3104), Querétaro City
Hemato Oncologos S.A. ( Site 2910), Santiago de Cali
"Communal Non-Commercial Enterprise Prykarpatski Clinical On-Department for daily treated patient (", Ivano-Frankivsk
Centre Henri Becquerel ( Site 0607), Rouen
University of Texas-MD Anderson Cancer Center ( Site 0087), Houston
Istituto Nazionale Tumori Fondazione Pascale ( Site 0705), Napoli
Banner MD Anderson Cancer Center ( Site 0092), Greeley
Universitaetsklinik der Ludwig-Maximilians-Universitaet Muenchen ( Site 0906), Munich
Utah Cancer Specialists ( Site 0038), West Valley City
Banner MD Anderson Cancer Center ( Site 0049), Gilbert
CHD Vendee ( Site 0604), La Roche-sur-Yon
Centro de Estudios de Investigacion Metabolicos y Cardiovasculares ( Site 3101), Madero
San Francisco Oncology Associates ( Site 0085), San Francisco
University of California San Francisco ( Site 0015), San Francisco
Institut Gustave Roussy ( Site 0602), Villejuif
UC Davis Comprehensive Cancer Center ( Site 0039), Sacramento
Northwest Medical Specialties, PLLC ( Site 0007), Tacoma
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1103), Craiova
Policlinica Oncomed SRL ( Site 1104), Timișoara
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1101), Cluj-Napoca
Medisprof ( Site 1102), Cluj-Napoca
Spitalul Judetean de Urgenta Alba Iulia ( Site 1107), Alba Iulia
Fundacion Valle del Lili ( Site 2909), Santiago de Cali
Rambam Health Care Campus-Oncology Division ( Site 0801), Haifa
Meir Medical Center ( Site 0804), Kfar Saba
Rabin Medical Center ( Site 0806), Petah Tikva
Chaim Sheba Medical Center ( Site 0800), Ramat Gan
Sourasky Medical Center ( Site 0805), Tel Aviv
Hadassah Ein Kerem Medical Center ( Site 0802), Jerusalem
Atlantic Health System ( Site 0046), Summit
Fundacion CIDEA ( Site 2704), Ciudad de Buenos Aires
Hospital Britanico de Buenos Aires ( Site 2705), Ciudad de Buenos Aires
Centro Medico Dra De Salvo ( Site 2702), Buenos Aires
CEMIC ( Site 2701), Buenos Aires
Centro Oncologico Riojano Integral ( Site 2703), La Rioja
BC Cancer-Vancouver Center ( Site 0203), Vancouver
Moncton Hospital - Horizon Health Network ( Site 0206), Moncton
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0201), Montreal
Fundación Colombiana de Cancerología Clínica Vida ( Site 2902), Medellín
Clinica de la Costa S.A.S. ( Site 2900), Barranquilla
Oncologika S.A. ( Site 3003), Guatemala City
Grupo Angeles SA ( Site 3004), Guatemala City
Sanatorio Nuestra Senora del Pilar ( Site 3006), Guatemala City
Medi-K Cayala ( Site 3005), Guatemala City
Centro Medico Integral De Cancerología (CEMIC) ( Site 3002), Quetzaltenango
Aichi Cancer Center Hospital ( Site 2504), Nagoya
National Cancer Center Hospital East ( Site 2500), Kashiwa
Hokkaido University Hospital ( Site 2502), Sapporo
Kyushu University Hospital ( Site 2506), Fukuoka
Okayama University Hospital ( Site 2505), Okayama
National Cancer Center Hospital ( Site 2501), Tokyo
Japanese Foundation for Cancer Research ( Site 2503), Tokyo
P. Stradina Clinical University Hospital ( Site 2102), Riga
CRYPTEX Investigacion Clinica S.A. de C.V. ( Site 3103), Mexico City
Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 1502), Ankara
Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 3206), Arequipa
Hospital Nacional Daniel Alcides Carrion ( Site 3207), Bellavista
Hospital Nacional Adolfo Guevara Velasco ( Site 3205), Cuzco
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warsaw
Uniwersyteckie Centrum Kliniczne ( Site 1809), Gdansk
Hematology and Oncology Institute ( Site 0504), Manatí
Ad-Vance Medical Research LLC ( Site 0505), Ponce
Pan American Center for Oncology Trials LLC ( Site 0501), Rio Piedras
FDI Clinical Research ( Site 0500), San Juan
Mary Potter Oncology Centre, Little Company of Mary Hospital ( Site 1900), Pretoria
Seoul National University Hospital ( Site 2402), Seoul
Severance Hospital Yonsei University Health System ( Site 2400), Seoul
Samsung Medical Center ( Site 2401), Seoul
Hospital Clinic i Provincial ( Site 1302), Barcelona
Skanes Universitetssjukhus Lund. ( Site 2001), Lund
Karolinska Universitetssjukhuset Solna ( Site 2000), Solna
Akademiska Sjukhuset ( Site 2002), Uppsala
Baskent University Adana Training Hospital ( Site 1509), Adana
Gazi Universitesi Tip Fakultesi ( Site 1507), Ankara
Ankara Sehir Hastanesi ( Site 1508), Ankara
Akdeniz Universitesi Tıp Fakultesi ( Site 1503), Antalya
Medical Centre Consilium Medical ( Site 1712), Kyiv
Merck Sharp & Dohme LLC
INDUSTRY